Home › Funds › Prudential Financial › FATE
Prudential Financial position in FATE
FATE THERAPEUTICS INC · Health Care
Latest position (Q1 2026)26.33K sh
Reported value held$31.60K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 73.02K | $4.42M | New |
| Q4 2021 | 6.83K | $408.00K | Reduce |
| Q1 2022 | 6.77K | $262.00K | Reduce |
| Q1 2023 | 159.91K | $911.49K | New |
| Q2 2023 | 66.31K | $315.64K | Reduce |
| Q3 2023 | 194.91K | $413.21K | Add |
| Q4 2023 | 560.01K | $2.09M | Add |
| Q1 2024 | 383.20K | $2.81M | Reduce |
| Q2 2024 | 356.10K | $1.17M | Reduce |
| Q3 2024 | 356.60K | $1.25M | Hold |
| Q4 2024 | 321.40K | $530.31K | Reduce |
| Q1 2025 | 73.29K | $57.91K | Reduce |
| Q2 2025 | 21.79K | $24.41K | Reduce |
| Q3 2025 | 43.19K | $54.42K | Add |
| Q4 2025 | 23.16K | $22.76K | Reduce |
| Q1 2026 | 26.33K | $31.60K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- BlackRock Inc 7.30M sh · $19.71M · Q2 2026
- AQR Capital Management 3.84M sh · $10.36M · Q2 2026
- Two Sigma Investments 3.59M sh · $9.69M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- Goldman Sachs Group 2.05M sh · $5.53M · Q2 2026
- Geode Capital Management 1.32M sh · $3.57M · Q2 2026
- Morgan Stanley 694.58K sh · $1.88M · Q2 2026
- Charles Schwab Investment Management 610.95K sh · $1.65M · Q2 2026
- UBS Group AG 590.18K sh · $1.59M · Q2 2026
- Marshall Wace 492.43K sh · $1.33M · Q2 2026